111 related articles for article (PubMed ID: 4354694)
1. The N6-(dimethylamino)methylene derivative of 9-beta-D-arabinofuranosyladenine as an antiviral agent.
Hanessian S
J Med Chem; 1973 Mar; 16(3):290-2. PubMed ID: 4354694
[No Abstract] [Full Text] [Related]
2. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
[No Abstract] [Full Text] [Related]
3. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL
J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice.
Dixon GJ; Sidwell RW; Miller FA; Sloan BJ
Antimicrob Agents Chemother (Bethesda); 1968; 8():172-9. PubMed ID: 4309849
[No Abstract] [Full Text] [Related]
5. Synthesis of N6- or 8-substituted 9-(beta-D-arabinofuranosyl)-adenines and their antiviral activities against herpes simplex and vaccinia viruses.
Kaneko M; Kimura M; Nishimura T; Shimizu B
Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2482-9. PubMed ID: 201386
[No Abstract] [Full Text] [Related]
6. Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.
Schardein JL; Sidwel RW
Antimicrob Agents Chemother (Bethesda); 1968; 8():155-60. PubMed ID: 4309847
[No Abstract] [Full Text] [Related]
7. [Research on substances with antiviral activity. X. 1-substituted-2-(methylamino) naphtho/2,1-b/furan hydrochlorides].
Chiarini A; Cavrini V; Giovanninetti G; Mannini Palenzona A; Baserga M
Farmaco Sci; 1979 Feb; 34(2):125-31. PubMed ID: 233363
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of aryl-furfurane derivatives.
Votyakov VI; Shashikhina MN; Izergina EA; Zhavrid SV; Stashkevich NP; Oleinik AF
Acta Virol; 1984 Jan; 28(1):33-8. PubMed ID: 6143495
[TBL] [Abstract][Full Text] [Related]
9. [Antiviral properties of fucidin].
Goncharskaia TIa; Navashin SM
Antibiotiki; 1971 Jan; 16(1):57-60. PubMed ID: 4324189
[No Abstract] [Full Text] [Related]
10. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
11. On the antiviral activity of diffusomycin (oxazolomycin).
Tonew E; Tonew M; Gräfe U; Zöpel P
Acta Virol; 1992 Mar; 36(2):166-72. PubMed ID: 1359768
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
Miller FA; Sloan BJ; Silverman CA
Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
[No Abstract] [Full Text] [Related]
13. [Course and treatment of herpervirus hominis infections. II. Therapy].
Luger A
Z Haut Geschlechtskr; 1971 Jul; 46(13):399-408. PubMed ID: 4331019
[No Abstract] [Full Text] [Related]
14. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
Sidwell RW; Dixon GJ; Schabel FM; Kaump DH
Antimicrob Agents Chemother (Bethesda); 1968; 8():148-54. PubMed ID: 5735359
[No Abstract] [Full Text] [Related]
15. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives.
Baker DC; Haskell TH; Putt SR; Sloan BJ
J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013
[TBL] [Abstract][Full Text] [Related]
16. 3-Substituted adenines. In vitro enzyme inhibition and antiviral activity.
Fujii T; Walker GC; Leonard NJ
J Med Chem; 1979 Feb; 22(2):125-9. PubMed ID: 218008
[TBL] [Abstract][Full Text] [Related]
17. New anti-HSV therapeutics target the helicase-primase complex.
Crumpacker CS; Schaffer PA
Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
[No Abstract] [Full Text] [Related]
18. [Chemistry and toxicology of a new antiviral agent: N-(1-adamantyl)-2-(2-dimethylamino-ethoxy)-acetamide-HCl.1].
Peteri D; Sterner W
Arzneimittelforschung; 1973 Apr; 23(4):577-81. PubMed ID: 4740238
[No Abstract] [Full Text] [Related]
19. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative.
Ikeda S; Yazawa M; Nishimura C
Antiviral Res; 1987 Oct; 8(3):103-13. PubMed ID: 2827566
[TBL] [Abstract][Full Text] [Related]
20. [Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo].
Wutzler P; Thiel KD; Tonew M; Tonew E; Schröer HP; Stelzner A
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):563-6. PubMed ID: 2830739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
